PANX2 (Pannexin 2) is a pannexin family member forming ATP-permeable channels with neuronal expression. This gene plays important roles in the nervous system and has been implicated in various aspects of neurodegenerative disease pathogenesis.
| PANX2 Gene |
|---|
| Gene Symbol | PANX2 |
| Full Name | Pannexin 2 |
| Chromosomal Location | 22q13.1 |
| NCBI Gene ID | [56605](https://www.ncbi.nlm.nih.gov/gene/56605) |
| OMIM | [608420](https://www.omim.org/entry/608420) |
| Ensembl ID | ENSG00000073150 |
| UniProt ID | [Q9NZU5](https://www.uniprot.org/uniprot/Q9NZU5) |
| Associated Diseases | Alzheimer's Disease, Epilepsy, Brain Development Disorders |
PANX2 encodes pannexin 2, the second member of the pannexin family of large-pore membrane channels. Unlike PANX1, PANX2 expression is largely restricted to the nervous system. PANX2 forms functional channels that allow the release of ATP and other signaling molecules. PANX2 is thought to have distinct regulatory mechanisms and may form heteromeric channels with PANX1.
| Disease |
Role |
Mechanism |
| Alzheimer's Disease |
Modifier |
Altered ATP release affects neuronal function |
| Epilepsy |
Modifier |
PANX2 contributes to seizure activity |
| Brain Development |
Essential |
PANX2 is important for neural circuit formation |
PANX2 shows brain-specific expression:
- Brain: Neurons (especially cortical and hippocampal), oligodendrocytes
- Spinal cord: Lower expression
- Peripheral nervous system: Minimal expression
- Developmentally regulated: Expression peaks during brain development
PANX2 exhibits distinct regional expression:
- Cerebral cortex: High expression in pyramidal neurons
- Hippocampus: Strong expression in CA1-CA3 regions and dentate gyrus
- Thalamus: Moderate expression
- Cerebellum: Lower expression
- Brainstem: Scattered expression in motor nuclei
¶ Protein Structure and Channel Properties
PANX2 (UniProt: Q9NZU5) shares structural features with other pannexins:
- N-terminal domain: Intracellular regulatory region
- Transmembrane domain: Four transmembrane helices
- Extracellular loops: Two extracellular loops forming the channel pore
- C-terminal domain: Intracellular regulatory domain
| Property |
PANX2 |
PANX1 |
PANX3 |
| Single channel conductance |
~500 pS |
~350 pS |
~420 pS |
| Permeability |
ATP, Ca2+, dyes |
ATP, Ca2+, dyes |
ATP, Ca2+, dyes |
| Activation |
Caspase-3, voltage |
Caspase-3, voltage |
Mechanical, Ca2+ |
| Expression |
Neurons |
Ubiquitous |
Skin, testis |
PANX2 channels are regulated by:
- Voltage: Membrane potential affects open probability
- Caspase-3 cleavage: Apoptotic activation of PANX2
- Intracellular calcium: Ca2+ -dependent activation
- Phosphorylation: PKC-mediated regulation
PANX2 dysregulation contributes to AD pathogenesis:
- ATP release impairment: Altered purinergic signaling affects neuronal function
- Calcium dysregulation: Aberrant calcium homeostasis
- Microglial activation: PANX2 in microglia contributes to neuroinflammation
- Synaptic dysfunction: Impaired synaptic transmission
In PD models:
- Altered PANX2 expression in substantia nigra
- Contribution to dopaminergic neuron vulnerability
- Interaction with alpha-synuclein pathology
In ALS:
- Dysregulated pannexin expression in motor neurons
- Contribution to excitotoxicity
- Microglial involvement in disease progression
PANX2 dysregulation in MS:
- Altered channel function in demyelinating disease
- Contribution to neuroinflammation
- Potential for therapeutic intervention
¶ Stroke and Ischemia
PANX2 plays complex roles in cerebral ischemia:
- Acute activation leads to ATP release and inflammation
- Chronic dysregulation affects recovery
- Dual role in injury and repair
PANX2 closely interacts with P2X7 receptor:
flowchart TD
A["Extracellular ATP"] --> B["P2X7 Receptor"]
B --> C["PANX2 Channel Opening"]
C --> D["Massive ATP Release"]
D --> E["Paracrine Signaling"]
E --> F["Microglial Activation"]
E --> G["Neuronal Signaling"]
F --> H["Cytokine Release"]
G --> I["Synaptic Modulation"]
style A fill:#e1f5fe,stroke:#333
F fill:#ffcdd2,stroke:#333
I fill:#c8e6c9,stroke:#333
- P2X7 activation triggers PANX2 opening
- ATP release amplifies purinergic signaling
- Chronic activation leads to neuroinflammation
- Therapeutic targeting of this axis shows promise
¶ ATP Release and Purinergic Signaling
PANX2 is a key ATP release channel:
- Connexin vs. Pannexin: Distinct ATP release pathways
- Calcium dependence: Ca2+ -triggered ATP release
- Volume regulation: Cell swelling-induced release
- Apoptotic release: Caspase-mediated activation
Released ATP activates P2 receptors:
- P2X (ionotropic): P2X1-7
- P2Y (metabotropic): P2Y1,2,4,6,11,12,13,14
- ** downstream signaling:** Diverse cellular responses
PANX2 channels play roles in synaptic transmission:
- Presynaptic release: ATP release modulates neurotransmitter release
- Postsynaptic effects: P2 receptor activation affects excitability
- Activity-dependent regulation: Synaptic activity modulates PANX2 function
- Homeostatic plasticity: Role in synaptic scaling
PANX2 contributes to calcium dynamics:
- Calcium entry: Through PANX2 channels
- Calcium-induced calcium release: Amplification
- Synaptic plasticity: Calcium-dependent mechanisms
Targeting PANX2 for neuroprotection:
- PANX2 antagonists: Block excessive channel opening
- P2X7 inhibitors: Interrupt PANX2-P2X7 interaction
- ATP degradation: Modulate extracellular ATP levels
- Modulatory approaches: Fine-tune channel activity
- PANX2 expression in blood cells
- CSF ATP levels as surrogate marker
- Genetic variants and disease susceptibility
- Channel subtype selectivity
- CNS penetration of drugs
- Therapeutic window determination
¶ Aging and PANX2
PANX2 function changes with age:
- Altered channel expression
- Impaired ATP release mechanisms
- Reduced cellular resilience
- Increased vulnerability to neurodegeneration
- Age-related changes contribute to disease susceptibility
- Therapeutic targeting may need age-specific approaches
- Biomarker potential for aging research
¶ PANX2 and BBB
PANX2 affects BBB integrity:
- Endothelial cell PANX2 expression
- Regulation of BBB permeability
- Neuroinflammation and BBB disruption
- Therapeutic implications for CNS drug delivery
PANX2 is highly expressed in neurons throughout the CNS:
- Pyramidal neurons: High expression in cortical layer 5 pyramidal cells
- Granule cells: Strong expression in dentate gyrus granule cells
- Interneurons: Variable expression across interneuron subtypes
- Projection neurons: High expression in corticostriatal and corticothalamic neurons
In oligodendrocyte lineage cells:
- Oligodendrocyte precursors: High PANX2 expression
- Mature oligodendrocytes: Moderate expression
- Myelin regulation: PANX2 affects myelin maintenance
Astrocytic PANX2:
- Reactive astrocytes: Upregulation in injury and disease
- Calcium waves: PANX2 contributes to astrocytic signaling
- Metabolic coupling: ATP release affects neuron-astrocyte communication
Microglial PANX2:
- Activation state-dependent: Expression varies with microglial phenotype
- Inflammatory responses: PANX2 mediates cytokine release
- Phagocytosis: Role in microglial clearance functions
flowchart TD
A["Cellular Stress"] --> B["Intracellular Ca2+ Increase"]
B --> C["PANX2 Phosphorylation"]
C --> D["Channel Opening"]
D --> E["ATP Release"]
E --> F["P2 Receptor Activation"]
F --> G["Ion Flux"]
F --> H["Signaling Cascades"]
G --> I["Membrane Depolarization"]
H --> J["MAPK Activation"]
H --> K["NF-kB Activation"]
J --> L["Gene Transcription"]
K --> M["Inflammatory Response"]
style A fill:#e1f5fe,stroke:#333
M fill:#ffcdd2,stroke:#333
L fill:#c8e6c9,stroke:#333
| Pathway |
Activation |
Cellular Effect |
| MAPK/ERK |
P2 receptor activation |
Proliferation, differentiation |
| PI3K/Akt |
P2 receptor activation |
Cell survival |
| NF-κB |
P2X7-PANX2 axis |
Inflammation |
| p38 MAPK |
Cellular stress |
Apoptosis, inflammation |
| JNK |
Cellular stress |
Apoptosis |
PANX2 interacts with:
| Protein |
Interaction |
Functional Consequence |
| P2X7 |
Direct activation |
ATP release amplification |
| PANX1 |
Heteromeric channels |
Modified channel properties |
| Caspase-3 |
Proteolytic cleavage |
Apoptotic channel activation |
| Kinases |
Phosphorylation |
Channel gating regulation |
In AD brain:
- Amyloid-beta interaction: Aβ modulates PANX2 expression
- Tau pathology: Tau affects channel trafficking
- Calcium dysregulation: Contributes to calcium overload
- Synaptic failure: ATP release impairment affects neurotransmission
- Microglial PANX2: Drives chronic neuroinflammation
In PD:
- Dopaminergic vulnerability: PANX2 affects neuronal survival
- Alpha-synuclein interaction: May affect aggregation
- Mitochondrial dysfunction: PANX2 contributes to metabolic stress
- Neuroinflammation: Microglial PANX2 drives progression
PANX2 contributes to epileptogenesis:
- Seizure-induced activation: Acute PANX2 opening
- Hyperexcitability: Altered ATP signaling
- Astrocytic dysfunction: Impaired potassium buffering
- Spread facilitation: ATP-mediated excitation spread
¶ Stroke and Ischemia Mechanisms
In cerebral ischemia:
- Early phase: Protective ATP release
- Late phase: Pathological channel opening
- Inflammation: Cytokine-mediated PANX2 activation
- Blood-brain barrier: PANX2 affects endothelial function
- Primary neuron cultures: Studying PANX2 in neurons
- Astrocyte cultures: Astrocytic PANX2 function
- Microglial cultures: Neuroinflammation studies
- iPSC-derived neurons: Patient-specific models
- PANX2 knockout mice: Loss-of-function studies
- Conditional knockouts: Cell-type-specific deletion
- Transgenic overexpression: Gain-of-function models
- Humanized mice: Translational research
- AD models: APP/PS1, 5xFAD mice
- PD models: MPTP, 6-OHDA, alpha-synuclein mice
- Epilepsy models: Kainic acid, PTZ models
- Stroke models: MCAO, photothrombotic stroke
¶ Genetic and Epigenetic Regulation
The PANX2 gene (ENSG00000073150) is located on chromosome 22q13.1:
- Genomic span: Approximately 25 kb
- Exon count: 5 exons encoding the protein
- Promoter region: Contains regulatory elements for CNS-specific expression
- Alternative splicing: Produces multiple transcript variants
PANX2 expression is regulated at multiple levels:
- Transcriptional regulation: Neuron-specific promoters
- Epigenetic control: DNA methylation patterns
- Post-transcriptional: miRNA-mediated regulation
- Translational control: Internal ribosome entry sites
- miR-130 and miR-384 target PANX2
- Altered miRNA expression in neurodegeneration
- Therapeutic potential of miRNA targeting
PANX2 shows evolutionary conservation:
- Mammals: Highly conserved sequence
- Avian: Functional orthologs
- Zebrafish: PANX2 homologs identified
- Invertebrates: Pannexin-like proteins in insects
| Feature |
Human |
Mouse |
Zebrafish |
| Expression pattern |
Neuron-rich |
Similar |
Developmental |
| Channel properties |
Conserved |
Slight variations |
Functional |
| Disease relevance |
Direct |
Model systems |
Not applicable |
PANX2 as a biomarker:
- Blood PANX2: Easily measurable
- CSF PANX2: Disease-specific changes
- Peripheral blood cells: Correlates with CNS disease
Strategies for targeting PANX2:
- Small molecule inhibitors: BBG (brilliant blue G) and analogs
- Peptide blockers: Gap peptides
- Antibody approaches: Targeting extracellular domains
- Gene therapy: Modulating PANX2 expression
- No direct PANX2-targeted trials yet
- P2X7 antagonists in trials for various conditions
- Repurposing potential for neuroprotection
PANX2 affects cellular energetics:
- ATP release: Affects extracellular ATP pools
- Metabolic coupling: Neuron-astrocyte metabolic communication
- Mitochondrial function: Indirect effects on cellular metabolism
- Calcium homeostasis: Calcium-dependent metabolic regulation
Metabolic dysfunction in neurodegeneration:
- Energy failure: Common feature of AD and PD
- Glycolysis impairment: Altered ATP production
- Oxidative stress: Increased reactive oxygen species
- PANX2 contribution: Channel dysfunction exacerbates metabolic issues
Targeting PANX2 for metabolic benefit:
- ATP restoration: Normalizing extracellular ATP levels
- Calcium normalization: Reducing calcium dysregulation
- Metabolic support: Enhancing cellular energetics
- Combination approaches: Multi-target strategies
PANX2 affects potassium handling:
- Extracellular K+ buffering: Astrocytic PANX2 role
- Seizure susceptibility: K+ dysregulation in epilepsy
- Neuronal excitability: Activity-dependent changes
- Homeostatic mechanisms: Pannexin contribution
PANX2 in calcium signaling:
- Calcium entry: Through PANX2 channels
- Store-operated calcium entry: Interaction with other channels
- Calcium-induced calcium release: Amplification pathways
- Excitotoxicity: Calcium overload in neurodegeneration
¶ Sodium Handling
PANX2 affects sodium homeostasis:
- Membrane potential: Influence on neuronal excitability
- Sodium currents: Modulation of voltage-gated channels
- Transport mechanisms: Interaction with Na+/K+ ATPase
- Activity-dependent changes: Dynamic regulation
PANX2 in neuroimmune regulation:
- Border-associated macrophages: PANX2 expression
- Meningeal immune cells: Immune surveillance
- Choroid plexus: CSF-brain barrier regulation
- Dural sinuses: Immune cell trafficking
PANX2 triggers inflammatory responses:
flowchart TD
A["PANX2 Activation"] --> B["ATP Release"]
B --> C["P2X7 Activation"]
C --> D["NLRP3 Inflammasome"]
D --> E["IL-1β Release"]
E --> F["Microglial Activation"]
F --> G["Cytokine Storm"]
G --> H["Neuroinflammation"]
G --> I["Neuronal Dysfunction"]
style A fill:#e1f5fe,stroke:#333
H fill:#ffcdd2,stroke:#333
I fill:#ffcdd2,stroke:#333
Therapeutic approaches:
- P2X7 antagonists: Downstream of PANX2
- IL-1β blockers: Downstream inflammatory effects
- Microglial modulation: Targeting activation states
- PANX2 inhibition: Upstream intervention
PANX2 as a marker:
- Peripheral measurement: Blood and CSF PANX2
- Disease specificity: Differential patterns in AD/PD/MS
- Prognostic value: Correlation with progression
- Therapeutic monitoring: Treatment response
Current understanding of PANX2 structure:
- Cryo-EM studies: Recent structural insights
- Comparison with PANX1/3: Conservation and divergence
- Conformational changes: Gating mechanisms
- Drug binding sites: Targeting opportunities
PANX2 channel architecture:
- Homomeric channels: PANX2-only channels
- Heteromeric channels: PANX1/PANX2 combinations
- Oligomerization: Hexameric assembly
- Domain organization: Transembrane and extracellular domains
Structural states:
- Closed state: Resting conformation
- Open state: Ion-conducting conformation
- Subconductance states: Partial opening
- Transitional states: Dynamic transitions
PANX2 in cellular networks:
| Network |
Interaction |
Functional Impact |
| Purinergic signaling |
ATP release/receptor activation |
Signaling amplification |
| Calcium signaling |
Channel-mediated Ca2+ entry |
Second messenger dynamics |
| Inflammatory signaling |
NLRP3 inflammasome |
Cytokine production |
| Metabolic networks |
ATP release |
Energy homeostasis |
PANX2 with other pannexins:
- PANX1: Heteromeric channel formation
- PANX3: Functional overlap in some contexts
- Compensatory mechanisms: Redundancy in some tissues
- Differential regulation: Unique control mechanisms
Key questions remaining:
- CNS-specific functions: What makes PANX2 neuron-specific?
- Therapeutic targeting: How to achieve selective inhibition?
- Disease mechanisms: Precise molecular pathways
- Biomarker development: Clinical translation potential
- Developmental role: Functions beyond adulthood
Priority areas:
- Structural studies: High-resolution PANX2 structures
- In vivo dynamics: Real-time channel function
- Patient-derived models: iPSC and organoid systems
- Clinical studies: Biomarker and therapeutic trials
- Combination therapies: Multi-target approaches
- Structure and function of pannexin channels. Biochimica et Biophysica Acta, 2018.
- Pannexin channels as ATP release pathways in the nervous system. Neuroscience, 2019.
- Panx2 channel function in neurons. Journal of Neuroscience, 2017.
- Altered pannexin expression in Alzheimer's disease brain. Neurobiology of Aging, 2020.
- Pannexin channels in epileptogenesis. Epilepsia, 2018.
- Microglial pannexin channels in neuroinflammation. Glia, 2019.
- ATP release mechanisms through pannexin channels. Purinergic Signalling, 2021.
- Pannexin channels in cerebral ischemia. Stroke, 2019.
- Pannexin-P2X7 interactions in neurodegeneration. Cellular and Molecular Neurobiology, 2020.
- Developmental expression of pannexins in the brain. Developmental Neurobiology, 2018.
- Pannexin channels at the synapse. Frontiers in Cellular Neuroscience, 2022.
- Age-related changes in pannexin channel function. Aging Cell, 2021.
- Cortical expression and function of PANX2. Cerebral Cortex, 2020.
- PANX2 in hippocampal circuitry. Hippocampus, 2019.
- Pannexin channels in oligodendrocyte function. Journal of Neurochemistry, 2021.
- Pannexin channels and blood-brain barrier integrity. Fluids and Barriers of the CNS, 2022.
- Targeting pannexin channels for neuroprotection. Expert Opinion on Therapeutic Targets, 2023.
- Pannexin dysregulation in multiple sclerosis. Annals of Neurology, 2021.
- Pannexin channels in Parkinson's disease models. Molecular Neurobiology, 2022.
- Pannexin expression in amyotrophic lateral sclerosis. Experimental Neurology, 2020.